2021 Fall Conference | N2 - Neuroscience in the Clinic: The Neurology of Obesity
Program Materials Program Evaluations
| 10:00 AM - 10:10 AM EDT | Introduction |
Case Presentation: An Obese Patient with MS
Ilana B. Katz Sand, MD |
| 10:10 AM - 10:40 AM EDT | Speaker |
The Neuroepidemiology of Obesity
Deborah Gustafson, PhD, MS |
| 10:40 AM - 11:10 AM EDT | Speaker |
Genetics of Body Weight Regulation
Satya Dash, MD, PhD |
| 11:10 AM - 11:20 AM EDT | Speaker |
Clinician Follow Up: Treatment Approaches
Ilana B. Katz Sand, MD |
| 11:20 AM - 11:30 AM EDT | Q&A |
Live Q&A
Riley Bove, MD, FAAN, Deborah Gustafson, PhD, MS, Ilana B. Katz Sand, MD, Satya Dash, MD, PhD |
| Riley Bove, MD, FAAN | Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeurologyLive. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Roche Genentech. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Eli Lilly. |
| Deborah Gustafson, PhD, MS | The institution of Deborah Gustafson, PhD, MS has received research support from National Institutes of Health. |
| Ilana B. Katz Sand, MD | The institution of Dr. Katz Sand has received research support from National Multiple Sclerosis Society. The institution of Dr. Katz Sand has received research support from Hirschl Foundation. The institution of Dr. Katz Sand has received research support from National Institutes of Health. Dr. Katz Sand has received personal compensation in the range of $500-$4,999 for serving as a Conference presenter with 好色先生. |
| Satya Dash, MD, PhD | Dr. Dash has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novonordisk . Dr. Dash has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Dash has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Dash has received research support from Canadian Institute of Health Research, Diabetes Canada, Heart & Stroke Foundation of Canada, Banting & Best Diabetes Centre, McLaughlin Centre. |